Associations Between Gastrointestinal Symptoms and COVID-19 Severity Outcomes Based on a Propensity Score–Weighted Analysis of a Nationwide Cohort
Background and Aims: Gastrointestinal (GI) symptoms are well-recognized manifestations of coronavirus disease 2019 (COVID-19). Our primary objective was to evaluate the association between GI symptoms and COVID-19 severity. Methods: In this nationwide cohort of US veterans, we evaluated GI symptoms...
Main Authors: | Shailja C. Shah, Andrew Canakis, Alese E. Halvorson, Chad Dorn, Otis Wilson, Jason Denton, Richard Hauger, Christine Hunt, Ayako Suzuki, Michael E. Matheny, Edward Siew, Adriana Hung, Robert A. Greevy, Jr., Christianne L. Roumie |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-01-01
|
Series: | Gastro Hep Advances |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2772572322001133 |
Similar Items
-
259 Proton pump inhibitor use is not significantly associated with severe COVID-19 related outcomes after extensive covariate adjustment
by: Shailja C. Shah, et al.
Published: (2022-04-01) -
Ascertainment of Helicobacter pylori Infection and Eradication Treatment Using a Nationwide Electronic Health Record Database
by: Shailja C. Shah, et al.
Published: (2024-01-01) -
Iron deficiency linked to altered bile acid metabolism promotes Helicobacter pylori–induced inflammation–driven gastric carcinogenesis
by: Jennifer M. Noto, et al.
Published: (2022-05-01) -
2156
by: Caroline Presley, et al.
Published: (2017-09-01) -
Helicobacter pylori Eradication Therapy Is Not Associated With Increased Risk of Cardiovascular Mortality, Based on a National Cohort Study
by: S.C. Shah, et al.
Published: (2022-01-01)